Filing Details
- Accession Number:
- 0001209191-15-043351
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-15 16:29:20
- Reporting Period:
- 2015-05-13
- Filing Date:
- 2015-05-15
- Accepted Time:
- 2015-05-15 16:29:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816284 | Celgene Corp | CELG | Pharmaceutical Preparations (2834) | 222711928 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1260573 | A Perry Karsen | C/O Celgene Corporation 86 Morris Avenue Summit NJ 07901 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-05-13 | 6,160 | $36.90 | 85,683 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-05-13 | 11,824 | $59.24 | 97,507 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-05-13 | 8,324 | $49.48 | 105,831 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-05-13 | 4,162 | $36.47 | 109,993 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-05-13 | 47,173 | $115.00 | 62,820 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2015-05-13 | 6,160 | $0.00 | 6,160 | $36.96 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-05-13 | 11,824 | $0.00 | 11,824 | $59.24 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-05-13 | 8,324 | $0.00 | 8,324 | $49.48 |
| Common Stock | Stock Option (right to buy) | Disposition | 2015-05-13 | 4,162 | $0.00 | 4,162 | $36.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-03-01 | No | 4 | M | Direct | |
| 5,912 | 2023-04-29 | No | 4 | M | Direct | |
| 4,162 | 2023-01-28 | No | 4 | M | Direct | |
| 0 | 2022-04-30 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 2,000 | Indirect | IRA Account |
| Common Stock | 1,639 | Indirect | 401(k) Plan |
Footnotes
- These shares were sold by the reporting person pursuant to a Rule 10b5-1 plan.
- The option was fully exercisable.
- The option was issued pursuant to the Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 17, 2013).
Billionaire Hedge Funds
